IUGNF Stock Latest News
Company AnnouncementsImugene posts strong azer-cel Phase 1b results, bolsters balance sheet and reshapes leadership3d ago
Company AnnouncementsImugene posts strong new responses in Phase 1b azer-cel trial for B-cell malignancies2w ago
Company AnnouncementsImugene Seeks ASX Quotation for Additional Ordinary Shares2w ago
Company AnnouncementsImugene Sets 2026 AGM, Flags Governance and Capital Management Resolutions3w ago
Company AnnouncementsImugene reshapes leadership as it sharpens focus on azer-cel CAR T program3w ago
Company AnnouncementsImugene Posts Strong Early Responses in Azer-cel BTKi Combo Trial4w agoCompany AnnouncementsImugene Director’s Options Expire, Adjusting Equity Mix Without New Dilution1M ago
- Company AnnouncementsImugene Issues 43.4 Million New Shares Under Capital Raising2M ago
Company AnnouncementsImugene seeks ASX quotation for 15.8 million new shares2M ago
Company AnnouncementsImugene Director’s Options Lapse Without Exercise2M ago- Company AnnouncementsImugene Posts Wider Loss and Sharp Fall in Net Tangible Assets2M ago
Company AnnouncementsImugene Restructures Convertible Notes and Raises Capital to Back Cancer Trials2M ago- Company AnnouncementsImugene Seeks ASX Quotation for 27.6 Million New Shares2M ago
- Company AnnouncementsImugene Restructures Convertible Notes to Boost Financial Flexibility2M ago
Company AnnouncementsImugene shareholders back capital-raising resolutions at extraordinary meeting2M ago
Company AnnouncementsImugene doubles down on azer-cel as leadership shifts and fresh capital backs trial push2M ago
Company AnnouncementsImugene’s Deep Out-of-the-Money Options Set to Expire Without Underwriting2M ago